PE20090292A1 - PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-SEIZURE AGENT - Google Patents

PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-SEIZURE AGENT

Info

Publication number
PE20090292A1
PE20090292A1 PE2008000866A PE2008000866A PE20090292A1 PE 20090292 A1 PE20090292 A1 PE 20090292A1 PE 2008000866 A PE2008000866 A PE 2008000866A PE 2008000866 A PE2008000866 A PE 2008000866A PE 20090292 A1 PE20090292 A1 PE 20090292A1
Authority
PE
Peru
Prior art keywords
agent
pharmaceutical composition
combination
composition including
inflammatory agent
Prior art date
Application number
PE2008000866A
Other languages
Spanish (es)
Inventor
Armenta Maria Elena Garcia
Murillo Josefina Santos
Ochoa Victor Guillermo Alvarez
Original Assignee
World Trade Imp Export Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40032120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20090292(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by World Trade Imp Export Wtie Ag filed Critical World Trade Imp Export Wtie Ag
Publication of PE20090292A1 publication Critical patent/PE20090292A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: a)UN AGENTE ANTICONVULSIVANTE, TAL COMO GABAPENTINA EN CANTIDAD DE 3mg A 300mg; b)UN AGENTE ANTIINFLAMATORIO NO ESTEROIDEO, TAL COMO MELOXICAM, EN CANTIDAD DE 0.1mg A 30mg. DICHA COMPOSICION ES ADMINISTRABLE POR VIA ORAL, EN FORMA DE CAPSULAS Y TABLETAS Y ES DE UTILIDAD EN EL TRATAMIENTO DE DOLOR NEUROPATICOIT REFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES: a) AN ANTI-CONFUSION AGENT, SUCH AS GABAPENTIN IN A QUANTITY OF 3mg TO 300mg; b) A NON-STEROID ANTI-INFLAMMATORY AGENT, SUCH AS MELOXICAM, IN A QUANTITY OF 0.1mg TO 30mg. SAID COMPOSITION IS ADMINISTRABLE BY ORAL ROUTE, IN THE FORM OF CAPSULES AND TABLETS AND IS USEFUL IN THE TREATMENT OF NEUROPATHIC PAIN

PE2008000866A 2007-05-21 2008-05-20 PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-SEIZURE AGENT PE20090292A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2007006093A MX2007006093A (en) 2007-05-21 2007-05-21 Pharmaceutical composition combining an anticonvulsant agent and an antiviral agent.

Publications (1)

Publication Number Publication Date
PE20090292A1 true PE20090292A1 (en) 2009-04-04

Family

ID=40032120

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000866A PE20090292A1 (en) 2007-05-21 2008-05-20 PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-SEIZURE AGENT

Country Status (7)

Country Link
AR (1) AR066668A1 (en)
CL (1) CL2008001476A1 (en)
CO (1) CO6241103A2 (en)
MX (1) MX2007006093A (en)
PE (1) PE20090292A1 (en)
UY (1) UY31095A1 (en)
WO (1) WO2008143490A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ508489A (en) * 1998-07-09 2004-06-25 Warner Lambert Co Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles

Also Published As

Publication number Publication date
CL2008001476A1 (en) 2008-07-11
MX2007006093A (en) 2009-02-25
UY31095A1 (en) 2008-11-28
WO2008143490A1 (en) 2008-11-27
AR066668A1 (en) 2009-09-02
CO6241103A2 (en) 2011-01-20

Similar Documents

Publication Publication Date Title
ES2916649T1 (en) Compositions and uses for the treatment of multiple sclerosis
FI3782612T3 (en) Oral formulations of cytidine analogs and methods of use thereof
AR078417A1 (en) SUBLINGUAL AND BUCAL FILM COMPOSITIONS
ECSP088239A (en) COMPOSITION OF SUSTAINED DRUG RELEASE
AR077138A1 (en) PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT HCV
PE20061314A1 (en) ASSOCIATION BETWEEN FERROQUINE AND A DERIVATIVE OF ARTEMISININ FOR THE TREATMENT OF MALARIA
CO6280474A2 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF EFFECTIVE EJACULATION
PE20120956A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BUPRENORPHINE AND NALMEFENE
BRPI0909211B8 (en) oral tablet-form formulation of tetracycline compounds
ECSP099734A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT
BR122016006880B8 (en) dosage form containing pantoprazole as active ingredient
AR062925A1 (en) METHOD FOR MANUFACTURING TABLETS CONTAINING PHARMACOLOGICALLY ACTIVE AGENTS
AR065917A1 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF A SUBLINGUAL TABLET THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY AND AN OPIACEAL ANALGESIC FOR PAIN MANAGEMENT
GT200800235A (en) FORMULATION OF LIQUID MEDICINAL PRODUCT
AR048958A1 (en) MEDICATION IN THE FORM OF A FILM FOR ADMINISTRATION VIA ORAL, CONTAINING ESTRIOL
PE20091030A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING THE COMBINATION OF A NON-STEROID ANTI-INFLAMMATORY AGENT AND A XANTHINE OXIDASE INHIBITING AGENT
PE20090292A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF A NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-SEIZURE AGENT
ES2544780T3 (en) Metadoxine for use as a liver fibrosis inhibitor
UY26176A1 (en) POLYMORPHIC FORMS OF A AZOBICICLO CITRATE (2,2,2) OCTAN-3-AMINE AND ITS PHARMACEUTICAL COMPOSITIONS.
ECSP099649A (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF A SUBLINGUAL TABLET THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY AND AN OPIACEAL ANALGESIC FOR PAIN MANAGEMENT
GT200700005A (en) STABLE PHARMACEUTICAL COMPOSITION OF CARISOPRODOL AND MELOXICAM
AR062613A1 (en) FORMULATION OF ORGANIC COMPOUNDS
PE20090316A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS
UY31856A (en) NEW ASSOCIATION OF ACTIVE INGREDIENTS CONTAINING AN ANTIFLAMMATORY, NON-STEROID PHARMACO AND A COLCHICOSIDE DERIVATIVE
PE20090725A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF AN ANTI-ARTHRITIC AGENT AND AN INTERLEUKIN-1 INHIBITING AGENT, USEFUL FOR THE CONTROL AND TREATMENT OF OSTEOARTHROSIS AND RELATED DISEASES

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed